Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway.
Yu M, Liu W, Li J, Lu J, Lu H, Jia W, Liu F. · 2020
Read Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. by Yu M, Liu W, Li J, Lu J, Lu H, Jia W, Liu F. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7425015.txt.
Description
Yu and co-authors test whether tiny cell parcels called exosomes can speed the healing of diabetic wounds. The exosomes came from bone marrow stem cells. Some stem cells were first treated with atorvastatin, a common statin drug.
In diabetic rats, shots of exosomes from treated cells closed skin wounds faster than plain exosomes. New blood vessels grew more strongly in the treated wounds. Tests on vein cells showed more growth, movement, and tube formation. The effect ran through the AKT/eNOS pathway and a small RNA called miR-221-3p. Blocking either one weakened the benefit. The authors propose treated-cell exosomes as a therapy for hard-to-heal diabetic skin wounds.
Catalog record
| CREATOR | Yu M, Liu W, Li J, Lu J, Lu H, Jia W, Liu F. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |